Brokerage firms like UBS have a neutral rating on Bharti Airtel, while Nomura has buy ratings on Macrotech Developers and BPCL. Additionally, Nuvama and Jefferies hold buy ratings on Federal Bank and Sun Pharma, respectively. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: UBS on Bharti Airtel: … Read more
After BSE has announced that it will discontinue Bankex weekly expiries, the market is rife with speculations that NSE may choose Nifty Bank over Nifty as both exchanges have to pick one expiry under new Sebi rules. Nifty Bank brings in higher volumes for the exchange, and better trading opportunities for speculators, but if Nifty … Read more
“I think the broader call one will have to take only post getting the clarity on the earnings picture. But my overall view is that the Nifty or the largecap companies by and large should hold out. I do not see a reason for a significant downward correction as far as the Nifty and the … Read more
“Mutual fund figures for I think the last month are still to come out, but they should be healthy. So, there are flows into mutual funds, PMS, AIF, etc. So, I think that keeps the market buoyant. On the other hand, we are also seeing huge supply these days, like on a daily basis now … Read more
“For this September series, we expect the range for September series for Nifty is 24,800 on the downside and on the higher side 25,600, this is going to be the possible range for Nifty. For Bank Nifty, the immediate supply zone which is placed is around 51,500 which is very important level to cross on … Read more
The first quarter earnings season is underway and as many as 88 companies will announce their quarterly numbers on Thursday. Key results to watch out for include ITC, Sun Pharma, Tata Motors, Adani Enterprises, Adani Ports, Zomato and Dabur. Apart from the above, companies like AB Capital, Clean Science Tech, Emami, Escorts Kubota, Indegene, Le … Read more
“I do not think the market is bracing for any kind of negative surprise at this point of time. And we do think that given the earnings that we have seen so far and the fact that we have underperformed US markets, there is a scope for some sort of an outperformance once the event … Read more
Various widely tracked companies like ITC, ONGC, IRFC, Ircon International, BHEL, BEL, Sun Pharma, Nykaa, Tata Investment Corporation, Hindalco, Ashok Leyland, and Divi’s lab will be releasing their March quarter report cards this week. Here’s a list: May 20ONGC, Indian Railway Finance Corporation (IRFC), Bharat Electronics (BEL), Oil India, SAIL, Deepak Nitrite, Whirlpool of India, … Read more
Technical charts indicate that Nifty and Bank Nifty are currently poised for an upward trend. According to technical analysts, Nifty may ascend towards 22,800 levels, while Bank Nifty could touch 48,500 levels. Stocks such as Sun Pharma, Hero MotoCorp, Tata Steel, Britannia, Divi’s Lab, HDFC Life, PI Industries, Praj Industries, and Sona BLW have exhibited … Read more
Brokerage firm HSBC maintained a buy rating on Sun Pharma, Citigroup recommended a buy rating on ICICI Bank, JPMorgan has an overweight rating on Bajaj Finance and CLSA recommended a buy rating on Avenue Supermarts. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: HSBC on Sun Pharma: … Read more